Alloway Paul 4
4 · Homology Medicines, Inc. · Filed Jan 5, 2024
Insider Transaction Report
Form 4
Alloway Paul
See Remarks
Transactions
- Sale
Common Stock
2024-01-03$0.57/sh−7,280$4,120→ 28,036 total
Footnotes (2)
- [F1]The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of restricted stock units.
- [F2]The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $0.058 to $0.58. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 2.